Lunch: Clinical Trials

1 trial of Lunch, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Lunch: new trials by email Literature Review of Lunch trials Research Report on Lunch

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon
rVSVΔG-ZEBOV-GP, V920, Fibre and equilibrate breakfast and lunch, Active detection and treatment of pathogens - Ebola Virus Disease
Phase 1 / Phase 2CompletedCentre de Recherche Médicale de Lambaréné1202021-04-092023-04-20

Conditions studied

Hemorrhagic Fever, Ebola (1)

Sponsors

Centre de Recherche Médicale de Lambaréné (1)

Countries

Gabon (1)